INFLUENCE OF CYP2C19 GENOTYPE AND SERUM PEPSINOGEN LEVEL ON FIRST-LINE ERADICATION THERAPY WITH ESOMEPRAZOLE FOR PATIENTS WITH HELICOBACTER PYLORI-POSITIVE GASTRITIS

Yoshimasa Saito  1     Hiroshi Serizawa  2     Yukako Kato  2     Masaru Nakano  3     Masahiko Nakamura     HIDEKAZU SUZUKI     Hidetsugu Saito    
1 Division Of Pharmacotherapeutics, Keio University Faculty Of Pharmacy, Tokyo, Japan;division Of Gastroenterology, Kitasato Institute Hospital, Tokyo, Japan
2 Division Of Gastroenterology, Kitasato Institute Hospital, Tokyo, Japan
3 Division Of Gastroenterology, Kitas

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing